UroGen Pharma's FDA nod for UGN-102 fuels recovery, but cash burn raises financing risks. Check out why I am maintaining my ...

Urogen Pharma Ltd. plans to launch its new product July 1 after the firm overcame a decidedly mixed FDA advisory panel meeting to nail down approval June 12 of Zusduri (mitomycin, formerly known as ...